News
News releases on January 8, 2024, page 3
Every news release public companies put out on January 8, 2024 (UTC): 483 news releases, newest first. Open any release to read it.
Spectrum Scholars applications open for new 2024-2025 class
Charter Communications, Inc. · Jan 8, 2024
Solid Biosciences Announces $109 Million Private Placement
Solid Biosciences Inc. · Jan 8, 2024
Solaris Resources Provides 2024 Preview Including Planned NYSE American Listing and Updated Warintza Mineral Resource Estimate in Q2/24
Solaris Resources Inc · Jan 8, 2024
SLR Investment Corp. Schedules the Release of its Financial Results for the Quarter and Fiscal Year Ended December 31, 2023
SLR Investment Corp. · Jan 8, 2024
SiTime to Present at the Needham Growth Conference on January 16, 2024
SiTime Corporation · Jan 8, 2024
Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
Sight Sciences, Inc. · Jan 8, 2024
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023
SI-BONE, Inc. · Jan 8, 2024
Shuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Gl...
Shuttle Pharmaceuticals Holdings, Inc. · Jan 8, 2024
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024
Shattuck Labs, Inc. · Jan 8, 2024
SenesTech Partners with Global Leader in Irrigation Solutions to Expand Evolve™ Soft Bait to Open Field Agriculture Applications
SenesTech, Inc. · Jan 8, 2024
Schrödinger Provides Update on Progress Across the Business and Outlines 2024 Development and Operational Goals
Schrodinger, Inc. · Jan 8, 2024
Scholastic Appoints Haji Glover as Chief Financial Officer
Scholastic Corporation · Jan 8, 2024
ScanSource Announces New Sales Leader for Intelisys
ScanSource, Inc. · Jan 8, 2024
Sarepta Therapeutics Reports Preliminary* Fourth Quarter and Full-Year 2023 Net Product Revenue
Sarepta Therapeutics, Inc. · Jan 8, 2024
SacValley MedShare Selects Health Catalyst to Power its Qualified Health Information Organization (QHIO)
Health Catalyst, Inc · Jan 8, 2024
Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
Royalty Pharma plc · Jan 8, 2024
Royalty Management Holding Corporation Announces Update with Pilot Scale Permanent Magnet Metal Alloys Program with Advanced Magnet Lab, ...
Royalty Management Holding Corporation · Jan 8, 2024
Rockwell Medical Amends Loan and Security Agreement with Innovatus Life Sciences Lending Fund
Rockwell Medical, Inc. · Jan 8, 2024
Roadzen Appoints Jean-Noël Gallardo as Global Chief Financial Officer
Roadzen, Inc. · Jan 8, 2024
Rio2 Issues Shares In Lieu of Salaries
RIO2 Limited · Jan 8, 2024
ReNew Signs Contract to Sell 300 MW Solar Project at a Valuation of $199 Million
ReNew Energy Global plc · Jan 8, 2024
Relay Therapeutics Announces $30 Million Private Placement Financing
Relay Therapeutics, Inc. · Jan 8, 2024
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
Recursion Pharmaceuticals, Inc. · Jan 8, 2024
Recurrent Energy Completes Sale of 100 MW/200 MWh Battery Energy Storage Project in South Australia to Epic Energy
Canadian Solar Inc. · Jan 8, 2024
RadNet, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 10th, 2024
RadNet, Inc. · Jan 8, 2024
Pulmatrix Announces Stopping the PUR1900 Phase 2B Study Patient Enrollment and Closing the Study, in Agreement With Partner Cipla, to Pre...
Pulmatrix, Inc. · Jan 8, 2024
PubMatic Leads the Way in Adopting Addressability Alternatives, Delivering Monetization Benefits for Publishers
PubMatic, Inc. · Jan 8, 2024
PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 42nd Annual J.P. Morgan Healthcare Conference
PTC Therapeutics, Inc. · Jan 8, 2024
Prothena Provides Updates on PRX012, PRX123, Birtamimab and Portfolio Programs
Prothena Corporation plc · Jan 8, 2024
Prosper Gold Commences Drilling at Golden Sidewalk Project
Prosper Gold Corp. · Jan 8, 2024
Progyny, Inc. to Present at 42nd Annual J.P. Morgan Healthcare Conference
Progyny, Inc. · Jan 8, 2024
PROCEPT BioRobotics® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million
PROCEPT BioRobotics Corporation · Jan 8, 2024
Preferred Bank Announces 2023 Fourth Quarter Earnings Release and Conference Call
Preferred Bank · Jan 8, 2024
Precigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conference
Precigen, Inc. · Jan 8, 2024
Praxis Precision Medicines Provides Update on Advancing Clinical Stage Portfolio
Praxis Precision Medicines, Inc. · Jan 8, 2024
Portofino Resources and Lithium Chile Partner on Winning Bid for 8,445 Hectare Arizaro Lithium Project in Salta, Argentina
LatAm Lithium Corp · Jan 8, 2024
Pluri Launches Advanced Global Cell Therapy Contract Development and Manufacturing Organization
Pluri Inc. · Jan 8, 2024
Plains All American Pipeline and Plains GP Holdings Announce Quarterly Distributions and Timing of Fourth-Quarter 2023 Earnings
Plains All American Pipeline, L.P. · Jan 8, 2024
Plains All American Pipeline and Plains GP Holdings Announce Quarterly Distributions and Timing of Fourth-Quarter 2023 Earnings
Plains GP Holdings, L.P. · Jan 8, 2024
Phillips Edison & Company Inc. Invites You to Join Its Fourth Quarter and Full Year 2023 Earnings Conference Call
Phillips Edison & Company, Inc. · Jan 8, 2024
PetMeds® Announces new Chairman of the Board
PetMed Express, Inc. · Jan 8, 2024
PepGen Announces First Patient Dosed in CONNECT1-EDO51 Phase 2 Clinical Trial of PGN-EDO51 for Duchenne Muscular Dystrophy Patients Amena...
PepGen Inc. · Jan 8, 2024
PCP Use of Clover Assistant Correlated with Increased Medication Fills for Patients who Were Previously Non-Adherent
Clover Health Investments, Corp. · Jan 8, 2024
Patterson-UTI Reports Drilling Activity for December 2023
Patterson-UTI Energy, Inc. · Jan 8, 2024
Patrick McFadden to Join Sinclair
Sinclair, Inc. · Jan 8, 2024
Pasithea Therapeutics Announces Invention of Crystalline Form of PAS-004; Establishes Strengthened Intellectual Property (IP) Position
Pasithea Therapeutics Corp. · Jan 8, 2024
Papa Johns Announces Back to Better 2.0 Ahead of 26th Annual ICR Conference, and Provides Preliminary 2023 Sales and Unit Development
Papa John's International, Inc. · Jan 8, 2024
PACCAR Highlights Heavy-Duty Innovation at CES 2024 with the Truck Industry’s Most Advanced Technologies
PACCAR Inc. · Jan 8, 2024
PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively
Pacific Biosciences of California, Inc. · Jan 8, 2024
Outset Medical Reports Unaudited Fourth Quarter and 2023 Revenue, Provides 2024 Revenue and Non-GAAP Gross Margin Guidance
Outset Medical, Inc. · Jan 8, 2024
OSI Systems Receives $59 Million Contract for Cargo and Vehicle Inspection Solutions
OSI Systems, Inc. · Jan 8, 2024
Osisko Gold Royalties Announces Q4 2023 GEO Deliveries, Record Cash Margin and Reduced Debt Balance
OR Royalties Inc. · Jan 8, 2024
Oscar Mayer Opens Applications to Get Behind the Wheel of an American Icon: The Wienermobile
The Kraft Heinz Company · Jan 8, 2024
OrthoPediatrics Corp. Announces Preliminary Unaudited Financial Highlights for the Fourth Quarter & Full Year 2023
OrthoPediatrics Corp. · Jan 8, 2024
OrthoPediatrics Corp. Announces Acquisition of Boston Orthotics & Prosthetics
OrthoPediatrics Corp. · Jan 8, 2024
Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer
Orthofix Medical Inc. · Jan 8, 2024
Origin Agritech Reports Fiscal Year End 2023 Results
Origin Agritech Limited · Jan 8, 2024
ORIC Pharmaceuticals Provides Initial Phase 1b Data for ORIC-944, Operational Highlights for 2023, and Anticipated Upcoming Milestones
Oric Pharmaceuticals, Inc. · Jan 8, 2024
Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients
Orchestra BioMed Holdings, Inc. · Jan 8, 2024
Option Care Health Selects Palantir’s Artificial Intelligence Platform for Enterprise-Wide Digital Transformation
Option Care Health, Inc. · Jan 8, 2024
OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Opko Health, Inc. · Jan 8, 2024
OneSpaWorld Announces Preliminary Fourth Quarter and Fiscal Year 2023 Revenue and EBITDA in line with Guidance and Introduces Fiscal 2024...
OneSpaWorld Holdings Limited · Jan 8, 2024
Olema Oncology Nominates OP-3136, an Orally Bioavailable KAT6 Inhibitor, as a Development Candidate
Olema Pharmaceuticals, Inc. · Jan 8, 2024
Ohmyhome and Webuy Announce Strategic Collaboration to Cross-Sell Products and Services Across Singapore
Ohmyhome Limited · Jan 8, 2024
Oak Valley Community Bank Announces Key Additions to Executive Management Team
Oak Valley Bancorp · Jan 8, 2024
Nuvalent Announces "OnTarget 2026" Operating Plan and Key Anticipated Milestones
Nuvalent, Inc. · Jan 8, 2024
Nurix Therapeutics Outlines 2024 Strategic Priorities with Advancement of Targeted Protein Modulation Pipeline in Cancer and Autoimmune D...
Nurix Therapeutics, Inc. · Jan 8, 2024
Nubia Brand International Corp. Provides Update on Closing of the Business Combination with Honeycomb Battery Company
Solidion Technology, Inc. · Jan 8, 2024
Novocure Announces Preliminary Full Year and Fourth Quarter 2023 Net Revenues and Provides Company Update
NovoCure Limited · Jan 8, 2024
Northern Trust Asset Management Names Co-Head of Wealth Client Group
Northern Trust Corporation · Jan 8, 2024
Northern Dynasty Minerals: Pebble Responds to US Supreme Court Decision to Deny Alaska’s Petition
Northern Dynasty Minerals Ltd. · Jan 8, 2024
NioBay Metals Intercepts Niobium in the Extension of Its Main Zone at Crevier
Niobay Metals Inc. · Jan 8, 2024
Nickel 28 Capital Releases Ramu 2023 Production and Provides 2024 Production Guidance
Nickel 28 Capital Corp · Jan 8, 2024
NGEx Minerals Drills 62 Metres At 6.98% Copper Equivalent And 63 Metres At 5.84% Copper Equivalent At Lunahuasi
NGEx Minerals Ltd. · Jan 8, 2024
Nextracker to Announce Third Quarter Fiscal 2024 Results on January 31, 2024
Nextpower Inc. · Jan 8, 2024
Nexstar Media Group to Report 2023 Fourth Quarter and Full Year Financial Results, Host Conference Call and Webcast on February 28
Nexstar Media Group, Inc. · Jan 8, 2024
Nexstar Media Enters Into Time Brokerage Agreement With KAZT-TV in Phoenix, Arizona
Nexstar Media Group, Inc. · Jan 8, 2024
Newell Brands Announces Organizational Realignment
Newell Brands Inc. · Jan 8, 2024
NewAmsterdam Pharma Appoints William H. Lewis, J.D., M.B.A. as Chair of its Board of Directors
NewAmsterdam Pharma Company N.V. · Jan 8, 2024
NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates
Neuropace, Inc. · Jan 8, 2024
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results
Neuronetics, Inc. · Jan 8, 2024
NerdWallet Announces Winners of its 2024 Best-Of Awards
NerdWallet, Inc. · Jan 8, 2024
NEO Battery Materials Announces Change of Business Completion on the TSX Venture Exchange to an Industrial, Technology, or Life Sciences ...
NEO Battery Materials Ltd · Jan 8, 2024
National CineMedia, U.S. Representative for Cannes Lions International Festival of Creativity, Launches the 2024 Young Lions Competition
National CineMedia, Inc. · Jan 8, 2024
Nasdaq European Markets sustains its strong position in the SME listings and sustainable debt market in 2023
Nasdaq, Inc. · Jan 8, 2024
MWC 2024: Amdocs Continues to Propel the Telecom Industry into the Generative AI Era with Amdocs CPQ Pro, Bringing Enterprise Growth Oppo...
Amdocs Limited · Jan 8, 2024
Monte Rosa Therapeutics Provides Corporate Update and Key Anticipated Milestones for 2024
Monte Rosa Therapeutics, Inc. · Jan 8, 2024
Montana Technologies Enters Joint Commercialization Agreement Term Sheet with Carrier Global to Provide Carbon-Reducing Cooling Technolog...
AirJoule Technologies Corporation · Jan 8, 2024
Monster Beverage Announces Webcast Details for Investor Meeting/Business Update January 16, 2024
Monster Beverage Corporation · Jan 8, 2024
Moderna Provides Business and Pipeline Updates at 42nd Annual J.P. Morgan Healthcare Conference
Moderna, Inc. · Jan 8, 2024
Mobileye Reveals New Wins for Key Tech Platforms with Large Global Automaker
Mobileye Global Inc. · Jan 8, 2024
MKS Instruments to Participate in Needham’s 26th Annual Growth Conference
MKS Inc. · Jan 8, 2024
Mistango River Resources Commences Goldie Drill Program
Stardust Metal Corp. · Jan 8, 2024
Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates
Mirum Pharmaceuticals, Inc. · Jan 8, 2024
Microchip Technology Provides Preliminary Fiscal Third Quarter Revenue Results and Announces Earnings Release Date
Microchip Technology Incorporated · Jan 8, 2024
MGP Promotes Amel Pasagic to Chief Commercial Officer
MGP Ingredients, Inc. · Jan 8, 2024
Mesa Laboratories Appoints Mark Capone to its Board of Directors
Mesa Laboratories, Inc. · Jan 8, 2024
Merit Medical Announces Projected Preliminary Unaudited Revenue for the Year Ended December 31, 2023 and Plans to Announce Fourth Quarter...
Merit Medical Systems, Inc. · Jan 8, 2024
MaxLinear Announces World’s First Wi-Fi CERTIFIED 7™ Tri-band Single Chip Solutions and Wi-Fi CERTIFIED 7 Tri-band Access Point
MaxLinear, Inc · Jan 8, 2024
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Results
MaxCyte, Inc. · Jan 8, 2024